SmartBreast Forms Molecular Breast Imaging Partnership with FITI
SmartBreast Forms Molecular Breast Imaging Partnership with FITI February 9, 2021 — After acquiring the molecular breast imaging (MBI) assets from GE Healthcare and Dilon Technologies, Inc., SmartBreast Corporation (SmartBreast), a privately held company focused on breast cancer screening and diagnosis, announced today that it has formed a partnership with FoxSemicon Integrated Technologies, Inc. (FITI) to manufacture molecular breast imaging (MBI) systems. FITI has invested substantially in SmartBreast and will be the contract manufacturer for two MBI systems recently acquired by Smar...
Source: itnonline.com